Location History:
- St. Lucia, AU (2012 - 2014)
- Blackburn North, AU (2014)
Company Filing History:
Years Active: 2012-2014
Title: Innovations of Nicholas E Shepherd
Introduction
Nicholas E Shepherd is a prominent inventor based in St. Lucia, Australia. He has made significant contributions to the field of peptide mimetics, with a focus on nociceptin and alpha-helical structures. His work has led to the development of innovative pharmaceutical compositions and methods for treating various conditions.
Latest Patents
Nicholas E Shepherd holds 3 patents. His latest patents include "Nociceptin mimetics," which relates to nociceptin peptide mimetics that possess α-helical structures and bind to the opioid receptor-like-1 (ORL-1) receptor. These peptide mimetics are designed as constrained cyclic nociceptin analogs that exhibit either agonist or antagonist activity. Additionally, he has developed "Alpha helical mimics, their uses and methods for their production," which discloses short chain peptides constrained to adopt an alpha helical conformation. These peptides serve as scaffolds for directing amino acid side chains into positions analogous to those found in longer chain alpha helical peptides.
Career Highlights
Nicholas E Shepherd is affiliated with the University of Queensland, where he continues to advance his research in peptide mimetics. His innovative work has garnered attention in the scientific community, contributing to the understanding of peptide interactions and their potential therapeutic applications.
Collaborations
Some of his notable coworkers include David P Fairlie and Rosemary Sharon Harrison. Their collaborative efforts have further enhanced the research output and impact of their work in the field.
Conclusion
Nicholas E Shepherd's contributions to the field of peptide mimetics demonstrate his commitment to innovation and research. His patents reflect a deep understanding of molecular interactions and their applications in medicine.